Profiles

Karen R. Jacobson, MD, MPH

Associate Professor, Epidemiology - Boston University School of Public Health

(617) 414-5213
karen.jacobson@bmc.org
Talbot
View Full Profile at BUMC

Biography

Dr. Karen Jacobson is an Associate Professor of Medicine in the Section of Infectious Diseases, Chobanian and Avedisian School of Medicine, with a secondary appointment in the Department of Epidemiology, Boston University School of Public Health. Dr. Jacobson’s research focuses on the epidemiology of tuberculosis, including identification of biological and social determinants of and risk factors for tuberculosis infection and disease (including drug resistant tuberculosis) and approaches for improving tuberculosis outcomes in resource-limited settings. Dr. Jacobson is the Medical Director of the Boston Medical Center Tuberculosis Clinic and has established a highly productive collaboration with researchers in Cape Town, South Africa. Her work has particular emphasis in understanding how substance use impacts on tuberculosis transmission and response to therapy.

Other Positions

  • Associate Professor, Medicine - Boston University Chobanian & Avedisian School of Medicine
  • Member, Evans Center for Interdisciplinary Biomedical Research - Boston University

Education

  • Johns Hopkins University School of Medicine, MD Field of Study: Medicine
  • Harvard School of Public Health, MPH Field of Study: Clinical Evaluation/Research
  • Yale University, BS Field of Study: Biology

Websites

Publications

  • Published on 4/10/2023

    Adeoye B, Nakiyingi L, Moreau Y, Nankya E, Olson AJ, Zhang M, Jacobson KR, Gupta A, Manabe YC, Hosseinipour MC, Kumwenda J, Sagar M. Mycobacterium tuberculosis disease associates with higher HIV-1-specific antibody responses. iScience. 2023 May 19; 26(5):106631. PMID: 37168567.

     Read At: PubMed
  • Published on 4/3/2023

    Sinha P, Jacobson KR, Horsburgh CR, Acuña-Villaorduña C. At Long Last: Short, All-Oral Regimens for Multidrug-Resistant Tuberculosis in the United States. Open Forum Infect Dis. 2023 Apr; 10(4):ofad177. PMID: 37125228.

     Read At: PubMed
  • Published on 2/15/2023

    Fofana AM, Moultrie H, Scott L, Jacobson KR, Shapiro AN, Dor G, Crankshaw B, Silva PD, Jenkins HE, Bor J, Stevens WS. Cross-municipality migration and spread of tuberculosis in South Africa. Sci Rep. 2023 Feb 15; 13(1):2674. PMID: 36792792.

     Read At: PubMed
  • Published on 2/8/2023

    Bouton TC, Atarere J, Turcinovic J, Seitz S, Sher-Jan C, Gilbert M, White L, Zhou Z, Hossain MM, Overbeck V, Doucette-Stamm L, Platt J, Landsberg HE, Hamer DH, Klapperich C, Jacobson KR, Connor JH. Viral Dynamics of Omicron and Delta Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants With Implications for Timing of Release from Isolation: A Longitudinal Cohort Study. Clin Infect Dis. 2023 Feb 08; 76(3):e227-e233. PMID: 35737948.

     Read At: PubMed
  • Published on 2/8/2023

    Petros BA, Turcinovic J, Welch NL, White LF, Kolaczyk ED, Bauer MR, Cleary M, Dobbins ST, Doucette-Stamm L, Gore M, Nair P, Nguyen TG, Rose S, Taylor BP, Tsang D, Wendlandt E, Hope M, Platt JT, Jacobson KR, Bouton T, Yune S, Auclair JR, Landaverde L, Klapperich CM, Hamer DH, Hanage WP, MacInnis BL, Sabeti PC, Connor JH, Springer M. Early Introduction and Rise of the Omicron Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant in Highly Vaccinated University Populations. Clin Infect Dis. 2023 Feb 08; 76(3):e400-e408. PMID: 35616119.

     Read At: PubMed
  • Published on 12/15/2022

    Muyindike WR, Fatch R, Cheng DM, Emenyonu NI, Forman L, Ngabirano C, Adong J, Linas B, Jacobson KR, Hahn JA. Unhealthy Alcohol Use Is Associated With Suboptimal Adherence to Isoniazid Preventive Therapy in Persons With HIV in Southwestern Uganda. J Acquir Immune Defic Syndr. 2022 Dec 15; 91(5):460-468. PMID: 36044285.

     Read At: PubMed
  • Published on 11/19/2022

    Malatesta S, Weir IR, Weber SE, Bouton TC, Carney T, Theron D, Myers B, Horsburgh CR, Warren RM, Jacobson KR, White LF. Methods for handling missing data in serially sampled sputum specimens for mycobacterial culture conversion calculation. BMC Med Res Methodol. 2022 Nov 19; 22(1):297. PMID: 36402979.

     Read At: PubMed
  • Published on 11/11/2022

    Turcinovic J, Schaeffer B, Taylor BP, Bouton TC, Odom-Mabey AR, Weber SE, Lodi S, Ragan EJ, Connor JH, Jacobson KR, Hanage WP. Understanding Early Pandemic Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in a Medical Center by Incorporating Public Sequencing Databases to Mitigate Bias. J Infect Dis. 2022 Nov 11; 226(10):1704-1711. PMID: 35993116.

     Read At: PubMed
  • Published on 10/1/2022

    Forman LS, Lodi S, Fatch R, Emenyonu NI, Adong J, Ngabirano C, Jacobson KR, Gerona R, Reckers AR, Gandhi M, Muyindike WR, Hahn JA. Agreement Between Measures of Adherence to Isoniazid Preventive Therapy Among People With HIV in Uganda. Open Forum Infect Dis. 2022 Oct; 9(10):ofac516. PMID: 36320196.

     Read At: PubMed
  • Published on 8/24/2022

    Barocas JA, Savinkina A, Lodi S, Epstein RL, Bouton TC, Sperring H, Hsu HE, Jacobson KR, Schechter-Perkins EM, Linas BP, White LF. Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling Study. Clin Infect Dis. 2022 Aug 24; 75(1):e1112-e1119. PMID: 34499124.

     Read At: PubMed

View 53 more publications:View Full Profile at BUMC

News & In the Media

View all profiles